This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
First Republic (FRC) Gets $30B Uninsured Deposits From US Banks
by Zacks Equity Research
11 US Banks have made an aggregate of $30-billion uninsured deposit into First Republic (FRC). This will ensure that FRC has enough liquidity to meet customers' withdrawals.
Zacks Industry Outlook Highlights JPMorgan Chase, Bank of America and The Bank of New York Mellon
by Zacks Equity Research
JPMorgan Chase, Bank of America and The Bank of New York Mellon are part of the Zacks Industry Outlook article.
3 Major Regional Banks Worth a Look Despite SVB, SBNY Collapse
by Swayta Shah
The contagion risk arising from bank runs, worsening asset quality and recession expectations will hurt Zacks Major Regional Banks' near-term performance. Yet, industry players like JPM, BAC & BK are worth a look on restructuring and digitization initiatives.
Can First Republic (FRC) Navigate Bank Solvency Jitters?
by Devyani Chamria
Investors drawing parallels between First Republic (FRC) and Silicon Valley should consider FRC's favorable balance-sheet mix and enhanced liquidity as aids to navigate the current jitters.
Looking to Buy Banks? Read these 3 Tips First
by Andrew Rocco
The banking sector has had a dark cloud hanging over it since the collapse of Silicon Valley Bank. Investors looking to get long the sector should do so in a methodical, risk averse manner.
JPMorgan Chase & Co. (JPM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Citigroup (C) Moves 6.0% Higher: Will This Strength Last?
by Zacks Equity Research
Citigroup (C) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Bank Failures and the Fed: Reason for Hope?
by Mark Vickery
We do see a chance the Fed pumps the brakes here -- and market participants may respond by picking up some relatively low-priced equities.
JPMorgan Chase & Co. (JPM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed at $131.25 in the latest trading session, marking a -1.8% move from the prior day.
Should You Buy the Dip in Big Bank ETFs Amid SVB Crisis?
by Sanghamitra Saha
Wall Street went into a tailspin last week due to the liquidation of Silicon Valley Bank and Silvergate Capital. Is it a case of specific business model failure or broad-based banking crisis?
U.S. Small and Mid-Sized Banks Plunge on SVB Debacle
by Zacks Equity Research
U.S. Small and Mid-Sized Banks Plunge on SVB Debacle.
Financial Earthquake Reverberates in Pre-Market
by Mark Vickery
Is this the "something breaking" that some analysts had warned would happen with the Fed aggressively raising interest rates over the past year?
SVB, SBNY Fallout: Why Contagion Risk to Other Banks is Remote
by Devyani Chamria
Considerable strength in the U.S. banking system and steps taken by agencies will prevent more bank runs like SVB Financial Group and Signature Bank (SBNY).
Regional Bank Armageddon: What you need to know
by Andrew Rocco
Regional Banks collapsed this week. Andrew Rocco walks you through what happened and what your next steps should be.
Should You Invest in the Invesco KBW Bank ETF (KBWB)?
by Zacks Equity Research
Sector ETF report for KBWB
Should Vanguard High Dividend Yield ETF (VYM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VYM
JPMorgan Chase & Co. (JPM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed at $142.82 in the latest trading session, marking a -0.58% move from the prior day.
Citigroup (C) Cuts Jobs Across IB and Mortgage Divisions
by Zacks Equity Research
Citigroup (C) cuts hundreds of jobs across the firm, with its IB and mortgage units being affected.
Investors Heavily Search JPMorgan Chase & Co. (JPM): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching JPMorgan Chase & Co. (JPM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
JPMorgan Chase & Co. (JPM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed the most recent trading day at $143.35, moving +0.84% from the previous trading session.
Wells Fargo (WFC) Reduces Mortgage Workforce on Strategy Rejig
by Zacks Equity Research
Wells Fargo (WFC) is eliminating more than 500 jobs from its mortgage unit workforce due to the company stepping back from the mortgage business.
Should You Invest in JPMorgan Chase & Co. (JPM) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JPMorgan Chase & Co. (JPM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
JPMorgan Chase & Co. (JPM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) closed the most recent trading day at $138.56, moving -0.77% from the previous trading session.
The Zacks Analyst Blog Highlights JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills
by Zacks Equity Research
JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills are part of the Zacks top Analyst Blog.
Top Stock Reports for JPMorgan Chase, Elevance Health & Vertex Pharmaceuticals
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Elevance Health, Inc. (ELV) and Vertex Pharmaceuticals Incorporated (VRTX).